New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
ImmunoPrecise Antibodies Ltd.
IPA
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

22M

Biotechnology

Next Earning date - 13 Mar 2025

22M

Biotechnology

Next Earning date - 13 Mar 2025

0.49USD

Shape-0.02 ( -3.33%)
moonAfter-hours 0.50$arrow-right-up0.01 (1.82%)
Market Closed (as of Feb 08, 00:17 EDT)
favorite-chart

Relative Strenght

21
favorite-chart

Volume Buzz

-88%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

80%

Quote Panel

Shape
Updated February 8, 2025
1W 12.43 % 1M -6.19 % 3M 10.74 % 1Y -77.05 %

Key Metrics

Shape
  • Market Cap

    22.48M


  • Shares Outstanding

    45.77M


  • Share in Float

    36.80M


  • Dividende

    0


  • Earning Date

    13 Mar 2025


  • Price Target

    0.4911


  • Average Volume

    6.28M


  • Beta

    0.273


  • Range

    0.325-2.43


  • Industry

    Biotechnology


  • Website

    https://www.ipatherapeutics.com


  • Sector

    Healthcare


Fundamentals

Shape

Relative Strength

Shape

IPA

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$25M

Shape309%

2025-Revenue

$0.39

Shape-335%

2025-EPS

$13M

Shape-830%

2025-EBITDA

Analyst rating

Strong Sell

Sell

Buy

Neutral

Strong Buy

Shape

Price Target

NaN(-100.00%)

Number of analyst

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-0.14
vs -0.16

Q2.23

arrow
arrow

N/A

-0.15
vs -0.17

Q3.23

arrow
arrow

N/A

-0.11
vs -0.30

Q4.23

arrow
arrow

N/A

-0.07
vs -0.23

Q1.24

arrow
arrow

N/A

-0.08
vs -0.14

Q2.24

arrow
arrow

N/A

-0.52
vs -0.15

Q3.24

arrow
arrow

N/A

-0.11
vs -0.11

Q4.24

arrow
arrow

N/A

-0.09
vs -0.07

Q1.25

arrow
arrow

N/A

-0.08
vs -0.08

Q2.25

arrow
arrow

N/A

-0.08
vs -0.52

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+7%

5.2M  vs 4.8M

Q2.23

arrow
arrow

+7%

5.6M  vs 5.2M

Q3.23

arrow
arrow

NA

4.7M  vs 4.7M

Q4.23

arrow
arrow

+19%

6.2M  vs 5.2M

Q1.24

arrow
arrow

+20%

6.2M  vs 5.2M

Q2.24

arrow
arrow

+15%

6.5M  vs 5.6M

Q3.24

arrow
arrow

+12%

5.3M  vs 4.7M

Q4.24

arrow
arrow

0%

6.1M  vs 6.2M

Q1.25

arrow
arrow

+6%

6.6M  vs 6.2M

Q2.25

arrow
arrow

+6%

6.8M  vs 6.5M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-8%

-0.08
vs -0.12

Q2.23

arrow
arrow

-9%

-0.09
vs -0.08

Q3.23

arrow
arrow

-14%

-0.14
vs -0.09

Q4.23

arrow
arrow

-5%

-0.05
vs -0.14

Q1.24

arrow
arrow

-6%

-0.06
vs -0.05

Q2.24

arrow
arrow

-53%

-0.53
vs -0.06

Q3.24

arrow
arrow

-12%

-0.12
vs -0.53

Q4.24

arrow
arrow

-8%

-0.08
vs -0.12

Institutionnal OwnershipShape

status-upQoQ

Q4.22

arrow
arrow

27

27
vs 23

17%

Q1.23

arrow
arrow

24

24
vs 27

-11%

Q2.23

arrow
arrow

19

19
vs 24

-21%

Q3.23

arrow
arrow

22

22
vs 19

16%

Q4.23

arrow
arrow

27

27
vs 22

23%

Q1.24

arrow
arrow

26

26
vs 27

-4%

Q2.24

arrow
arrow

21

21
vs 26

-19%

Q3.24

arrow
arrow

17

17
vs 21

-19%

Earnings Growth

Latest News